InflaRx N.V. Profile Avatar - Palmy Investing

InflaRx N.V.

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of…
Biotechnology
DE, Jena [HQ]
Competitors · Subsidiaries · Locations

Context Analysis

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Competitors Table
Competitor Private? Source Accuracy Country City
- - - -
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of IFRX's Analysis
CIK: 1708688 CUSIP: N44821101 ISIN: NL0012661870 LEI: - UEI: -
Secondary Listings
IFRX has no secondary listings inside our databases.